Therefore, NPAR’s value extends beyond simply combining two biomarkers—it integrates neutrophilia-driven vascular injury with albumin-modulated metabolic and anti-inflammatory homeostasis into a single metric that more comprehensively reflects the complex pathophysiology underlying cardiovascular disease progression. This evidence concerns the gene ALB and cardiovascular disorder.